Pediatrics Department chair Jordan Orange, MD, PhD was recently awarded prestigiousa MERIT (Method To Extend Research in Time) Award from the National Institute of Allergy and Infectious Diseases.
Lewis Silverman, MD will join the Department of Pediatrics as director of the Hope and Heroes Division of Pediatric Hematology, Oncology and Transplantation.
Columbia’s researchers have opened a trial of a noninvasive, focused ultrasound approach to open the blood-brain barrier, enabling higher concentrations of an effective drug to enter the brain.
Dr. Adolfo Ferrando and his lab members focus primarily on deciphering the mechanisms that lead to chemotherapy resistance and relapse in acute lymphoblastic leukemia.
Columbia’s pediatric hematology/oncology/stem cell transplantation team is launching a groundbreaking program in pediatric neuro-oncology, the Brain Tumor Technology Research (BTTR) initiative.
Columbia researchers are exploring ways to repurpose drugs approved by the FDA for other conditions and existing experimental therapies in difficult-to-treat pediatric cancers.
Columbia's Dr. Prakash Satwani is researching ways to reduce immediate and late-stage complications in bone marrow transplantation for children with leukemia/lymphoma.
Maureen Licursi, NP cares for children with lifelong genetic diseases and long-term chronic illnesses, such as sickle cell disease, helping them throughout all stages of their treatment.
Through new research studies Dr. Stergios Zacharoulis hopes to impact the currently dismal outlook for the 4,000 children in the US diagnosed each year with a brain or spinal cord tumor.